Consequently, although obesity affects hundreds of millions of people globally, GLP-1 therapies currently reach only a small fraction of eligible patients, underscoring the substantial unmet need for more convenient, scalable, and accessible treatment options
Best medical experience I've had in years." Terika M
Metabolic Syndrome and Retatrutide : Metabolic syndrome is a cluster of conditions, including high blood pressure, high blood sugar, abnormal cholesterol levels, and excess abdominal fat, that significantly increase the risk of developing cardiovascular disease and type 2 diabetes
The bubbles will float to the top near the needle
Retatrutide pushed that number to 16% at 4 mg, 22% at 8 mg, and 33-34% at 12 mg
These medications mimic GLP-1, a naturally occurring hormone, and help you feel full for longer after eating as well as manage your blood sugar